The US Sunshine Act, diabetes in China and Allergan interviewed

Pharmaceutical Market Europe PME June 2014In this month’s PME, out this week in both its print and online forms, we speak to Allergan’s Paul Navarre and Paul Boland for our lead interview and hear how they’re creating a culture of growth.

The June issue also takes a look at the Sunshine Act and finds that the US legislation’s implications are anything but clear for European pharma, and there are features on diabetes marketing, communications and commercial relationships in China and the consumerisation of mHealth.

There’s also a look at the emergence of cancer immunotherapies in our regular pipeline feature and an introduction to our forthcoming collaboration with European healthcare communications group the HCC.

• Read the June 2014 issue of PME in full online


, , , , , , , , ,

  1. Leave a comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: